Two Onc Docs cover image

Anal Cancer 2025 UPDATE

Two Onc Docs

00:00

2025 Update: Retifanlimab with Carboplatin–Paclitaxel

They present the May 2025 FDA approval of retifanlimab plus carboplatin/paclitaxel from the PODIUM-303 trial.

Play episode from 07:31
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app